S
SYNTESE A/S
Syntese is dedicated to continuously innovating and improving our product and our process so we can continue to supply our customers with: the best quality product possible a product that matches the customer's specific formula a product at a competitive price a product delivered right on time Syntese has also other competitive assets: worldwide marketing certification GMP certification FDA approval for delivery to the US Syntese is an environmentally conscious company - something proven by our ISO 14001 certification, our ambitious energy reduction projects, annual environmental reports and our Copenhagen County Environmental Award.
Country/Area ：Denmark
Company Email ：info@darmanyab.com
Industry ：Manufacturing GeneralManufacturingChemicals
Company address ：11-13 Industriholmen, Hvidovre, Capital Region, 2650, Denmark
Company website ：*****
Company phone ：+45 36340030
Established ：-
Company Revenue ：$7,014,000
Number of employees ：28
SIC Code ：28283
NAICS Code ：32325
Main Products ：--
Web Summary
Q1: What is the address of Synthése A/S?
A1: The address of Synthése A/S is not explicitly mentioned in the provided text, but it can be inferred that as a subsidiary of Ferring, it may have its headquarters or main office located at Ferring's global headquarters.
Q2: What products does Synthése A/S manufacture?
A2: According to the text, Synthése A/S manufactures mesalazine, an Active Pharmaceutical Ingredient (API), which is used in drug product formulations for the treatment of inflammatory bowel diseases such as ulcerative colitis or Crohn’s disease.
Q3: In what industry does Synthése A/S operate?
A3: Synthése A/S operates in the pharmaceutical industry, specifically in the production and manufacturing of APIs and pharmaceutical products for the treatment of inflammatory bowel diseases.
Q4: What services does Synthése A/S provide to its customers?
A4: The text does not explicitly mention the services provided by Synthése A/S. However, as a manufacturer of APIs and pharmaceutical products, it can be inferred that Synthése A/S provides quality assurance, product certification, and other services related to the production and supply of pharmaceutical products.
Q5: What is the contact information for Synthése A/S?
A5: The provided text mentions several contact numbers and email addresses for different countries and territories where Ferring has a presence. However, it does not provide a single, unified contact number or email address for Synthése A/S as a whole.
Q6: What is the company's focus on improving quality of life for people with inflammatory bowel diseases?
A6: According to the text, Synthése A/S is committed to helping people with inflammatory bowel diseases live better lives. The company aims to improve the quality of life for this patient group by developing and manufacturing high-quality pharmaceutical products that can effectively treat their condition.
Q7: What is the history of Synthése A/S?
A7: The text provides a brief history of Synthése A/S, which dates back to the early 1980s when a team of employees from Ferring's Synthesis department developed a new purification process for 5-aminosalicylic acid to obtain the API mesalazine. This led to the launch of Pentasa in 1986 and the implementation of an approved synthesis process in 2001.
Q8: What is the relationship between Synthése A/S and Ferring?
A8: According to the text, Synthése A/S is a subsidiary of Ferring, which means that its employees are part of something larger while also having the sense of working in a close-knit community. This relationship allows Synthése A/S to benefit from Ferring's resources and expertise while maintaining its independence as a smaller company.
A1: The address of Synthése A/S is not explicitly mentioned in the provided text, but it can be inferred that as a subsidiary of Ferring, it may have its headquarters or main office located at Ferring's global headquarters.
Q2: What products does Synthése A/S manufacture?
A2: According to the text, Synthése A/S manufactures mesalazine, an Active Pharmaceutical Ingredient (API), which is used in drug product formulations for the treatment of inflammatory bowel diseases such as ulcerative colitis or Crohn’s disease.
Q3: In what industry does Synthése A/S operate?
A3: Synthése A/S operates in the pharmaceutical industry, specifically in the production and manufacturing of APIs and pharmaceutical products for the treatment of inflammatory bowel diseases.
Q4: What services does Synthése A/S provide to its customers?
A4: The text does not explicitly mention the services provided by Synthése A/S. However, as a manufacturer of APIs and pharmaceutical products, it can be inferred that Synthése A/S provides quality assurance, product certification, and other services related to the production and supply of pharmaceutical products.
Q5: What is the contact information for Synthése A/S?
A5: The provided text mentions several contact numbers and email addresses for different countries and territories where Ferring has a presence. However, it does not provide a single, unified contact number or email address for Synthése A/S as a whole.
Q6: What is the company's focus on improving quality of life for people with inflammatory bowel diseases?
A6: According to the text, Synthése A/S is committed to helping people with inflammatory bowel diseases live better lives. The company aims to improve the quality of life for this patient group by developing and manufacturing high-quality pharmaceutical products that can effectively treat their condition.
Q7: What is the history of Synthése A/S?
A7: The text provides a brief history of Synthése A/S, which dates back to the early 1980s when a team of employees from Ferring's Synthesis department developed a new purification process for 5-aminosalicylic acid to obtain the API mesalazine. This led to the launch of Pentasa in 1986 and the implementation of an approved synthesis process in 2001.
Q8: What is the relationship between Synthése A/S and Ferring?
A8: According to the text, Synthése A/S is a subsidiary of Ferring, which means that its employees are part of something larger while also having the sense of working in a close-knit community. This relationship allows Synthése A/S to benefit from Ferring's resources and expertise while maintaining its independence as a smaller company.
Customs Data
As a purchaser
As a Supplier
Get the Whole details
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Get the Whole details
